23rd August 2023
Researchers show how cancer cells rearrange their inner workings to squeeze between obstacles
Read more28th July 2023
The findings could help us to distinguish who will benefit from treatment
Read more15th June 2023
The findings could help explain why cancer drugs that target the molecule MET work for some people but not others.
Read more15th May 2023
The results suggest new strategies to overcome the cancer’s defences and treat patients more effectively
Read more10th November 2022
Researchers from Barts Cancer Institute at Queen Mary University of London have identified a new channel of communication through which non-cancerous cells drive the invasion of cancer cells in pancreatic cancer. By blocking a particular signalling molecule within this pathway, called Fibroblast Growth Factor Receptor 1, the team was able to reduce invasion of pancreatic cancer cells in the laboratory.
Read more12th October 2022
Professor Fran Balkwill from Barts Cancer Institute at Queen Mary University of London has received a UK Research and Innovation (UKRI) Frontier Research grant of over £2 million to investigate the most effective ways to remodel cancers to enhance the effects of immunotherapy.
Read more